Description
Rabeprazole Sodium Injection (IV)
Healthy Inc is a specialized global supplier and exporter of high-stability gastrointestinal injectables. We provide Rabeprazole Sodium Injection (20 mg), manufactured in our WHO–GMP certified facilities. This fast-acting PPI is exported to hospitals and pharmacy networks in Africa, LATAM, CIS, and Southeast Asia for the acute management of severe acid-peptic disorders and erosive GERD.
Product Overview
Rabeprazole is a substituted benzimidazole Proton Pump Inhibitor (PPI). It suppresses gastric acid secretion by inhibiting the gastric H+/K+ ATPase enzyme.
Key Advantages:
- Rapid Onset: Rabeprazole has a higher pKa value than other PPIs, leading to faster activation in the parietal cells and quicker acid suppression.
- Acute Therapy: Ideal alternative when oral therapy is not feasible (e.g., patients with severe vomiting or difficulty swallowing).
- ZES Management: Effective control of hypersecretion in Zollinger-Ellison Syndrome.
Product Composition & Strength
We supply this product as a **Sterile Lyophilized Powder** to ensure maximum potency and shelf-life.
| Active Ingredient | Strength | Form |
|---|---|---|
| Rabeprazole Sodium | 20 mg | Lyophilized Powder |
*Supplied with 5ml or 10ml Sterile Water for Injection (SWFI) diluent.
Technical & Logistics Specifications
Critical data for Pharmaceutical Importers and Hospital Tenders.
| HS Code | 3004.90.99 (Medicaments for therapeutic uses) |
| Dosage Form | Lyophilized Powder for Injection (Vial) |
| Route of Administration | Intravenous (IV) Injection / Infusion |
| Packaging | Glass Vial with Flip-off Seal (Tray Pack / Combo Pack) |
| Storage | Store below 25°C. Protect from light and moisture. |
| Certificates | WHO-GMP, COPP, FSC, CTD Dossier |
Manufacturing Authority
Manufactured at our WHO-GMP & ISO 9001:2015 certified unit.
- Lyophilization: Advanced freeze-drying technology ensures the product remains stable in tropical climates without degradation.
- Purity: Low moisture content (< 3%) guarantees rapid reconstitution and solution clarity.
- Capacity: Automated filling lines for high-volume export orders.
Therapeutic Indications
Indicated for the short-term treatment of:
- Active Duodenal Ulcer: Rapid healing of ulcers with severe symptoms.
- Active Benign Gastric Ulcer: Management of acute gastric lesions.
- Erosive GERD: Symptomatic Gastroesophageal Reflux Disease with esophageal erosion.
- Hypersecretory Conditions: Pathological hypersecretion (Zollinger-Ellison Syndrome).
Dosage & Administration
Strict Medical Supervision Required (Hospital Use):
- Standard Dose: 20 mg once daily via Intravenous Injection.
- Method: Reconstitute with 5ml Sterile Water for Injection. Inject slowly over 5 to 15 minutes.
- Infusion: Can be further diluted with 0.9% Sodium Chloride and administered as a short infusion.
- Duration: Intravenous therapy should be discontinued as soon as the patient can take oral medication (usually 7-10 days).
Warnings:
- Liver Function: Use with caution in patients with severe hepatic impairment.
- Usage: Use immediately after reconstitution. Do not store the reconstituted solution.
Commercial Inquiries
For hospital tenders, bulk export, or distributor pricing, please contact our export team.
WhatsApp/Call: +91 7710003340
Email: info@healthyinc.co.in
